239 related articles for article (PubMed ID: 26186432)
1. Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study.
Xiong GL; Prybol K; Boyle SH; Hall R; Streilein RD; Steffens DC; Krishnan R; Rogers JG; O'Connor CM; Jiang W;
Psychosom Med; 2015 Sep; 77(7):808-15. PubMed ID: 26186432
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Markers Profile in Older Adolescents During Treatment with Selective Serotonin Reuptake Inhibitors.
Martins LB; Delevati Colpo G; Calarge CA; Teixeira AL
J Child Adolesc Psychopharmacol; 2021 Aug; 31(6):439-444. PubMed ID: 34166063
[No Abstract] [Full Text] [Related]
3. Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs.
Shelton RC; Pencina MJ; Barrentine LW; Ruiz JA; Fava M; Zajecka JM; Papakostas GI
J Clin Psychiatry; 2015 Dec; 76(12):1635-41. PubMed ID: 26613389
[TBL] [Abstract][Full Text] [Related]
4. Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study.
Michalakeas CA; Parissis JT; Douzenis A; Nikolaou M; Varounis C; Andreadou I; Antonellos N; Markantonis-Kiroudis S; Paraskevaidis I; Ikonomidis I; Lykouras E; Kremastinos D
J Card Fail; 2011 Sep; 17(9):748-54. PubMed ID: 21872145
[TBL] [Abstract][Full Text] [Related]
5. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS
BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.
Bot M; Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Mann DL
J Psychosom Res; 2011 Jul; 71(1):13-7. PubMed ID: 21665007
[TBL] [Abstract][Full Text] [Related]
7. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.
Glassman AH; Bigger JT; Gaffney M; Shapiro PA; Swenson JR
Arch Gen Psychiatry; 2006 Mar; 63(3):283-8. PubMed ID: 16520433
[TBL] [Abstract][Full Text] [Related]
8. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.
Leo R; Di Lorenzo G; Tesauro M; Razzini C; Forleo GB; Chiricolo G; Cola C; Zanasi M; Troisi A; Siracusano A; Lauro R; Romeo F
J Clin Psychiatry; 2006 Nov; 67(11):1760-6. PubMed ID: 17196057
[TBL] [Abstract][Full Text] [Related]
9. Major depressive disorder and inflammatory markers in elderly patients with heart failure.
Andrei AM; Fraguas R; Telles RM; Alves TC; Strunz CM; Nussbacher A; Rays J; Iosifescu DV; Wajngarten M
Psychosomatics; 2007; 48(4):319-24. PubMed ID: 17600168
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress, inflammation and treatment response in major depression.
Lindqvist D; Dhabhar FS; James SJ; Hough CM; Jain FA; Bersani FS; Reus VI; Verhoeven JE; Epel ES; Mahan L; Rosser R; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2017 Feb; 76():197-205. PubMed ID: 27960139
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.
O'Connor CM; Jiang W; Kuchibhatla M; Silva SG; Cuffe MS; Callwood DD; Zakhary B; Stough WG; Arias RM; Rivelli SK; Krishnan R;
J Am Coll Cardiol; 2010 Aug; 56(9):692-9. PubMed ID: 20723799
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants.
Glassman AH; Bigger JT; Gaffney M
Arch Gen Psychiatry; 2009 Sep; 66(9):1022-9. PubMed ID: 19736359
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.
Jiang W; O'Connor C; Silva SG; Kuchibhatla M; Cuffe MS; Callwood DD; Zakhary B; Henke E; Arias RM; Krishnan R;
Am Heart J; 2008 Sep; 156(3):437-44. PubMed ID: 18760123
[TBL] [Abstract][Full Text] [Related]
14. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
[TBL] [Abstract][Full Text] [Related]
15. Sertraline treatment of major depression in patients with acute MI or unstable angina.
Glassman AH; O'Connor CM; Califf RM; Swedberg K; Schwartz P; Bigger JT; Krishnan KR; van Zyl LT; Swenson JR; Finkel MS; Landau C; Shapiro PA; Pepine CJ; Mardekian J; Harrison WM; Barton D; Mclvor M;
JAMA; 2002 Aug; 288(6):701-9. PubMed ID: 12169073
[TBL] [Abstract][Full Text] [Related]
16. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis.
Wang L; Wang R; Liu L; Qiao D; Baldwin DS; Hou R
Brain Behav Immun; 2019 Jul; 79():24-38. PubMed ID: 30797959
[TBL] [Abstract][Full Text] [Related]
17. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study.
Vaccarino V; Brennan ML; Miller AH; Bremner JD; Ritchie JC; Lindau F; Veledar E; Su S; Murrah NV; Jones L; Jawed F; Dai J; Goldberg J; Hazen SL
Biol Psychiatry; 2008 Sep; 64(6):476-83. PubMed ID: 18514165
[TBL] [Abstract][Full Text] [Related]
18. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.
Glassman AH; Bigger JT; Gaffney M; Van Zyl LT
Arch Gen Psychiatry; 2007 Sep; 64(9):1025-31. PubMed ID: 17768267
[TBL] [Abstract][Full Text] [Related]
19. Sertraline with desvenlafaxine and sertraline with mirtazapine as treatment initiation in MDD patients with moderate to severe depression and effect on inflammatory markers.
Arockiaraj N; Gupta R; Ahmad R; Halder S; Bhatia MS
Int J Psychiatry Clin Pract; 2024 Mar; 28(1):9-16. PubMed ID: 38019131
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder].
Xiang JJ; Hong S; Ran LY; Zeng Q; Kong YT; Zhang CY; Liao J; Kuang L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):310-315. PubMed ID: 36949691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
